Total Payments
$20,476
2024 Payments
$12,237
Companies
5
Transactions
18
Medicare Patients
772
Medicare Billing
$139,768

Payment Breakdown by Category

Other$13,080 (63.9%)
Travel$4,546 (22.2%)
Consulting$2,100 (10.3%)
Food & Beverage$750.60 (3.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,080 2 34.6%
Honoraria $6,000 2 29.3%
Travel and Lodging $4,546 4 22.2%
Consulting Fee $2,100 1 10.3%
Food and Beverage $750.60 9 3.7%

Top Paying Companies

Company Total Records Latest Year
SpringWorks Therapeutics, Inc. $7,380 8 $0 (2024)
Epizyme, Inc., $6,000 2 $0 (2021)
Ipsen Biopharmaceuticals, Inc $4,857 5 $0 (2024)
Bayer HealthCare Pharmaceuticals Inc. $2,100 1 $0 (2021)
Novartis Pharmaceuticals Corporation $139.08 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,237 13 SpringWorks Therapeutics, Inc. ($7,380)
2021 $8,100 3 Epizyme, Inc., ($6,000)
2017 $139.08 2 Novartis Pharmaceuticals Corporation ($139.08)

All Payment Transactions

18 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/13/2024 SpringWorks Therapeutics, Inc. OGSIVEO (Drug) Food and Beverage In-kind items and services $36.59 General
Category: DESMOID TUMORS
11/13/2024 SpringWorks Therapeutics, Inc. OGSIVEO (Drug) Food and Beverage In-kind items and services $26.14 General
Category: DESMOID TUMORS
11/13/2024 SpringWorks Therapeutics, Inc. OGSIVEO (Drug) Food and Beverage In-kind items and services $7.84 General
Category: DESMOID TUMORS
11/13/2024 SpringWorks Therapeutics, Inc. OGSIVEO (Drug) Food and Beverage In-kind items and services $7.84 General
Category: DESMOID TUMORS
11/12/2024 SpringWorks Therapeutics, Inc. OGSIVEO (Drug) Food and Beverage In-kind items and services $135.00 General
Category: DESMOID TUMORS
06/27/2024 SpringWorks Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,600.00 General
06/27/2024 SpringWorks Therapeutics, Inc. Travel and Lodging Cash or cash equivalent $3,396.85 General
06/15/2024 Ipsen Biopharmaceuticals, Inc Tazverik (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,480.00 General
Category: Oncology
06/15/2024 Ipsen Biopharmaceuticals, Inc Tazverik (Drug) Travel and Lodging In-kind items and services $563.31 General
Category: Oncology
06/15/2024 Ipsen Biopharmaceuticals, Inc Tazverik (Drug) Travel and Lodging In-kind items and services $306.11 General
Category: Oncology
06/15/2024 Ipsen Biopharmaceuticals, Inc Tazverik (Drug) Travel and Lodging In-kind items and services $279.50 General
Category: Oncology
06/15/2024 Ipsen Biopharmaceuticals, Inc Tazverik (Drug) Food and Beverage In-kind items and services $228.14 General
Category: Oncology
05/07/2024 SpringWorks Therapeutics, Inc. OGSIVEO (Drug) Food and Beverage In-kind items and services $169.97 General
Category: DESMOID TUMORS
06/08/2021 Epizyme, Inc., TAZVERIK (Drug) Honoraria Cash or cash equivalent $3,000.00 General
Category: ONCOLOGY
05/21/2021 Epizyme, Inc., TAZVERIK (Drug) Honoraria Cash or cash equivalent $3,000.00 General
Category: ONCOLOGY
05/18/2021 Bayer HealthCare Pharmaceuticals Inc. Vitrakvi (Drug) Consulting Fee Cash or cash equivalent $2,100.00 General
Category: Oncology
11/08/2017 Novartis Pharmaceuticals Corporation VOTRIENT (Drug) Food and Beverage In-kind items and services $62.66 General
Category: ONCOLOGY
10/13/2017 Novartis Pharmaceuticals Corporation VOTRIENT (Drug) Food and Beverage In-kind items and services $76.42 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 142 302 $141,311 $31,032
2022 8 226 396 $155,522 $37,504
2021 7 211 413 $174,501 $43,763
2020 9 193 329 $129,361 $27,469
Total Patients
772
Total Services
1,440
Medicare Billing
$139,768
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 75 192 $102,554 $20,052 19.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 21 63 $18,039 $6,005 33.3%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 20 20 $11,160 $2,815 25.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 13 13 $7,863 $1,822 23.2%
99441 Telephone medical discussion with physician, 5-10 minutes Facility 2023 13 14 $1,695 $337.32 19.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 74 162 $83,247 $17,659 21.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 32 105 $29,715 $8,559 28.8%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 22 22 $11,814 $3,220 27.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 17 17 $9,799 $2,666 27.2%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 21 22 $6,778 $1,869 27.6%
99497 Advance care planning, first 30 minutes Facility 2022 23 26 $6,300 $1,656 26.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 22 22 $5,544 $1,289 23.3%
99441 Telephone medical discussion with physician, 5-10 minutes Facility 2022 15 20 $2,325 $587.17 25.3%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 88 237 $117,243 $27,390 23.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 22 67 $18,961 $5,638 29.7%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 33 33 $17,142 $4,891 28.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 16 17 $9,178 $2,791 30.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 15 15 $4,397 $1,297 29.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 15 20 $4,876 $1,101 22.6%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2021 22 24 $2,704 $654.50 24.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 63 164 $78,394 $13,315 17.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 18 45 $12,979 $3,887 30.0%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 27 27 $13,918 $3,455 24.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 16 17 $8,779 $2,845 32.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 18 21 $4,902 $1,201 24.5%

About Ravin Ratan

Ravin Ratan is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2009. The National Provider Identifier (NPI) number assigned to this provider is 1265674600.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ravin Ratan has received a total of $20,476 in payments from pharmaceutical and medical device companies, with $12,237 received in 2024. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,080).

As a Medicare-enrolled provider, Ratan has provided services to 772 Medicare beneficiaries, totaling 1,440 services with total Medicare billing of $139,768. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

Products in Payments

  • TAZVERIK (Drug) $6,000
  • Tazverik (Drug) $4,857
  • Vitrakvi (Drug) $2,100
  • OGSIVEO (Drug) $383.38
  • VOTRIENT (Drug) $139.08

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Houston